# Respicardia, Inc. Pivotal Trial of the remedē System

Study · id `cardio:ct-nct01816776` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01816776](<https://clinicaltrials.gov/study/NCT01816776>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01816776

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 151 participants.

## Technical summary

Registry record NCT01816776. Randomized; no masking; primary purpose treatment. Start 2013-03 (registry gives no type); primary completion 2016-09-10 (actual). Results posted on 2017-07-11.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 151 participants (enrolled count; ClinicalTrials.gov record NCT01816776, source copy `cardio:ctgov-nct01816776-2018-06-29`, retrieved 2026-10-26)
- Start date: 2013-03 (registry gives no type) (ClinicalTrials.gov record NCT01816776, source copy `cardio:ctgov-nct01816776-2018-06-29`, retrieved 2026-10-26)
- Primary completion: 2016-09-10 (actual) (ClinicalTrials.gov record NCT01816776, source copy `cardio:ctgov-nct01816776-2018-06-29`, retrieved 2026-10-26)
- Completion: 2017-11-07 (actual) (ClinicalTrials.gov record NCT01816776, source copy `cardio:ctgov-nct01816776-2018-06-29`, retrieved 2026-10-26)
- Results first posted: 2017-07-11 (ClinicalTrials.gov record NCT01816776, source copy `cardio:ctgov-nct01816776-2018-06-29`, retrieved 2026-10-26)
- Countries: United States; Germany; Poland (ClinicalTrials.gov record NCT01816776, source copy `cardio:ctgov-nct01816776-2018-06-29`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01816776-2018-06-29`, retrieved 2026-10-26)

## The registry's words

- Brief title: Respicardia, Inc. Pivotal Trial of the remedē System
- Condition: Sleep Apnea, Central
- Condition: Sleep Disordered Breathing
- Condition: Heart Failure
- Intervention (Device): Treatment Group (transvenous stimulation of the phrenic nerve)
- Intervention (Device): Control Group (Optimal Medical Therapy)
- Lead sponsor: Respicardia, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Improving Nocturnal Hypoxemic Burden with Transvenous Phrenic Nerve Stimulation for the Treatment of Central Sleep Apnea (`cardio:pubmed-32789619`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Transvenous phrenic nerve stimulation improves central sleep apnea, sleep quality, and quality of life regardless of prior positive airway pressure treatment (`cardio:pubmed-33745107`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Transvenous phrenic nerve stimulation is associated with normalization of nocturnal heart rate perturbations in patients with central sleep apnea (`cardio:pubmed-37284759`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Classifying hypopneas as obstructive or central can enhance transvenous phrenic nerve stimulation therapy patient selection and outcomes (`cardio:pubmed-41025409`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Automatic activation of neurostimulation for central sleep apnea results in high nightly usage (`cardio:pubmed-41761012`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Changes in quality of life in patients with atrial fibrillation and central sleep apnea treated with transvenous phrenic nerve stimulation (`cardio:pubmed-41643229`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: e7f7bd196e99ea8ed6923587b0239c445eec35751435e6c2a63fa54eb59d5c67
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
